Long intergenic non-protein coding RNA 1733 (LINC01733)

Long intergenic non-protein coding RNA 1733 (LINC01733) is a **long non-coding RNA (lncRNA) gene**, meaning it is transcribed into RNA but does not encode a protein[1][3]. Like other lncRNAs, it is thought to exert regulatory functions at the RNA level, potentially influencing gene expression, chromatin structure, and epigenetic processes[7][9]. There is very limited data specifically on LINC01733's biological effects or disease associations, and it does not currently appear in drug-target or biomarker lists. By analogy to other lincRNAs, such as LINC01133, similar molecules can regulate cellular processes such as proliferation, migration, invasion, and epigenetic modification, and may have roles in cancer[2]. However, LINC01733 itself has not at present been specifically established as a therapeutic target or biomarker in any disease, nor are drugs known to act on it directly[1][3]. **Summary of findings:** - LINC01733 is a specific long non-coding RNA gene, not a protein-coding gene, enzyme, receptor, or classic drug target[1][3]. - There is no evidence that LINC01733 is a direct therapeutic target or current drug target[1][3]. - Detailed functional, disease, or drug interaction data for LINC01733 is currently lacking in the scientific literature and genomic databases reviewed. - This is distinct from LINC01133, a related but different lincRNA, which has reported roles in cancer and gene regulation[2]. If structured or functional annotations for this target become available, these fields can be updated accordingly.

Other names

LINC01733long intergenic non-protein coding RNA 1733